Dry Eye Screening and Referral System
The Development of Artificial Intelligence Dry Eye Screening and Referral System
1 other identifier
observational
518
1 country
1
Brief Summary
Dry eye is one of the most common ocular surface diseases. Its pathogenic factors are related to multiple etiology. Because of the complexity of the pathogenesis of dry eye, the diversity of related examinations, and the inconsistency of symptoms and signs of dry eye patients, the diagnosis of dry eye has higher requirements on the professional technology and examination equipment of ophthalmologists. The purpose of this study is to establish a case-control cohort of dry eye patients. Multimodal data will be collected from participants, including medical history information, ocular surface disease index scale (OSDI), anterior segment photography, and treatment outcome of dry eye patients. The correlation between the characteristics of anterior segment images and dry eye diagnosis will be explored by artificial intelligence algorithms. The purpose of this study was to develop an artificial intelligence dry eye screening and referral system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2020
CompletedFirst Submitted
Initial submission to the registry
May 28, 2020
CompletedFirst Posted
Study publicly available on registry
June 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedApril 25, 2022
April 1, 2022
2.3 years
May 28, 2020
April 18, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Area under the curve (severe)
AUC values for predicting whether subject need to be referral or not.
up to 1 month
Secondary Outcomes (2)
Area under the curve (each group)
up to 1 month
Accuracy, true positive rate, and true negative rate
up to 1 month
Study Arms (3)
Severe Group
This group of subjects needed a referral to the hospital for further treatments.
Mild group
This group of subjects was diagnosed with dry eye but can use artificial tears instead of further treatment.
Follow-up group
This group of subjects had no dry eye symptoms and signs and belonged to the normal control group.
Interventions
The artificial intelligent dry eye screening platform
Eligibility Criteria
Subjects who are equal or over 18 years old with or without dry eye symptoms and signs.
You may qualify if:
- Subjects whose age are greater than or equal to 18 years old;
- Subjects who can cooperate with the inspection;
- Subjects who agree to participate in the study and sign the consent form.
You may not qualify if:
- Subjects who cannot do the inspection.
- Subjects who suffer from diseases that compromise the inspection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510632, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 28, 2020
First Posted
June 2, 2020
Study Start
January 6, 2020
Primary Completion
April 19, 2022
Study Completion
August 1, 2022
Last Updated
April 25, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share